Riskpilot← Back to searchSign inGet full accessBiokol Sverige AB
ABActiveOrg 5566575501StockholmEngineering activities and related technical consultancy · NACE 7112Est. 20040 employees
Revenue 2025
SEK 292K
+134% vs 2024
EBITDA margin
-36.8%
-186% vs 2024
Equity ratio
18.7%
Financial strength
Net profit 2025
SEK -160K
+19% vs 2024
| Revenue | SEK 292K | +134% |
| EBITDA | SEK -108K | -186% |
| Net profit | SEK -160K | +19% |
| Total assets | SEK 794K | -3% |
| Equity | SEK 149K | +129% |
| Employees | 0 | — |
Legal name
Biokol Sverige AB
Org number
5566575501
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11 mars 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är tillverkning och försäljning av material av förnyelsebara bränslen och därmed förenlig verksamhet.
Address
Stockholm
Email
malte.lilliestrale@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 711 | 598 | 270 | 125 | 292 |
| Staff expenses | — | — | −4 | −4 | −3 |
| EBITDA | 506 | −53 | 537 | 125 | −108 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 506 | −53 | 537 | 125 | −108 |
| Net financials | −140 | −129 | −6 | −323 | −52 |
| Profit before tax | 366 | −183 | 531 | −198 | −160 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 366 | −183 | 531 | −198 | −160 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 178 | 714 | 1 138 | 816 | 794 |
| Equity | −662 | −845 | −314 | −512 | 149 |
| Long-term debt | 94 | 19 | 0 | — | — |
| Short-term debt | 1 746 | 1 540 | 1 452 | 1 328 | 646 |
| Total debt | 1 840 | 1 559 | 1 452 | 1 328 | 646 |
EBITDA margin
-36.8%
This company
15.8%
Market median
-333% vs market
20212025
Equity ratio
18.7%
This company
38.2%
Market median
-51% vs market
20212025
Return on equity
-107.3%
This company
18.4%
Market median
-683% vs market
20212025
Net profit margin
-54.6%
This company
8.1%
Market median
-774% vs market
20212025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212025
Debt / equity
4.34×
This company
0.62×
Market median
-600% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biokol Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malte Carl Joachim Lilliestråle | Chief Executive Officer | 0 companies |
| Anna Margareta Lilliestråle | Deputy Board Member | 0 companies |